Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc.

NASDAQ:JSPR

Overview | Financials
Company Name Jasper Therapeutics, Inc.
Symbol JSPR
Currency USD
Price 18.63
Market Cap 281,411,739
Dividend Yield 0%
52-week-range 4 - 31.01
Industry Biotechnology
Sector Healthcare
CEO Mr. Ronald A. Martell
Website https://jaspertherapeutics.com

An error occurred while fetching data.

About Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic

Related Stocks

Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc.

HOWL

2.02 USD

Annexon, Inc. logo

Annexon, Inc.

ANNX

5.75 USD

UroGen Pharma Ltd. logo

UroGen Pharma Ltd.

URGN

13.23 USD

CVRx, Inc. logo

CVRx, Inc.

CVRX

8.42 USD

Financials

Numbers are in millions USD

Numbers are in millions USD